1. Home
  2. ASMB vs TLS Comparison

ASMB vs TLS Comparison

Compare ASMB & TLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Assembly Biosciences Inc.

ASMB

Assembly Biosciences Inc.

N/A

Current Price

$28.30

Market Cap

440.0M

Sector

Health Care

ML Signal

N/A

Logo Telos Corporation

TLS

Telos Corporation

N/A

Current Price

$4.20

Market Cap

317.1M

Sector

Technology

ML Signal

N/A

Company Overview

Basic Information
Metric
ASMB
TLS
Founded
2005
1969
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
EDP Services
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
440.0M
317.1M
IPO Year
2010
2020

Fundamental Metrics

Financial Performance
Metric
ASMB
TLS
Price
$28.30
$4.20
Analyst Decision
Strong Buy
Buy
Analyst Count
6
5
Target Price
$43.40
$7.75
AVG Volume (30 Days)
92.6K
687.5K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
50.00
N/A
EPS
N/A
N/A
Revenue
N/A
$108,272,000.00
Revenue This Year
$33.33
$52.26
Revenue Next Year
N/A
$19.65
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$7.76
$1.83
52 Week High
$39.71
$8.36

Technical Indicators

Market Signals
Indicator
ASMB
TLS
Relative Strength Index (RSI) 48.18 41.72
Support Level $26.50 $3.82
Resistance Level $30.66 $4.73
Average True Range (ATR) 1.46 0.22
MACD 0.04 0.06
Stochastic Oscillator 36.74 38.46

Price Performance

Historical Comparison
ASMB
TLS

About ASMB Assembly Biosciences Inc.

Assembly Biosciences Inc is a clinical-stage biotechnology company. It is advancing two platform programs, a novel class of oral therapeutics for the treatment of hepatitis B virus (HBV) infection and novel class of oral synthetic live biotherapeutics, which are designed to restore health to a dysbiotic microbiome. The company's HBV-cure program is aimed at increasing the current low cure rate for patients with HBV and is pursuing multiple drug candidates that inhibit multiple steps of the HBV lifecycle. Assembly has discovered several novel core protein Allosteric Modulators, which are small molecules that directly target and allosterically modulate the HBV core protein. The majority of the revenue is generated from the HBV cure program.

About TLS Telos Corporation

Telos Corp offers technologically forwarded, software-based security solutions that empower and protect the world's security-conscious organizations against rapidly evolving, sophisticated, and pervasive threats. Its business has two reportable and operating segments namely Security Solutions and Secure Networks. The Security Solutions segment focuses on cybersecurity, cloud, and identity solutions, and the Secure Networks focuses on enterprise security. The company derives maximum revenue from the Security Solutions segment.

Share on Social Networks: